Manual medical drafting and code translation bottlenecked clinical experts. Now, secure AI generates first drafts for human review.
A global biopharmaceutical organization developing treatments for severe neurological and immunological conditions must manage rapidly growing data volumes within a highly regulated environment.
Clinical teams faced heavy administrative burdens, from generating first drafts of medical documents to manually translating large volumes of...
“AI is an enabler for UCB. It helps us be more productive, but it also opens up completely new possibilities in research and development.”
Biopharmaceutical company focused on neurology and immunology treatments.
Enterprise software, cloud infrastructure, and consumer electronics platform.
Related implementations across industries and use cases
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Scientists spent half a day digging through 50 years of scattered files. Now, an AI assistant retrieves past experiments in minutes.
Drug developers lost days hunting for research across scattered PDFs. Now, they query an AI agent for instant answers, accelerating R&D.
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Teams spent weeks manually merging trial data. AI now generates drafts with full lineage, shifting experts to verification.
Manual scheduling trapped recruiters in logistics. AI now automates interview coordination, freeing teams for strategic work.
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Hundreds of pages per board book slowed director prep. Now, isolated AI securely condenses sensitive materials into actionable briefs.
Experts spent 15 minutes pulling data from scattered systems. Natural language prompts now generate detailed reports instantly.
Manual medical drafting and code translation bottlenecked clinical experts. Now, secure AI generates first drafts for human review.
A global biopharmaceutical organization developing treatments for severe neurological and immunological conditions must manage rapidly growing data volumes within a highly regulated environment.
Clinical teams faced heavy administrative burdens, from generating first drafts of medical documents to manually translating large volumes of...
“AI is an enabler for UCB. It helps us be more productive, but it also opens up completely new possibilities in research and development.”
Biopharmaceutical company focused on neurology and immunology treatments.
Enterprise software, cloud infrastructure, and consumer electronics platform.
Related implementations across industries and use cases
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Scientists spent half a day digging through 50 years of scattered files. Now, an AI assistant retrieves past experiments in minutes.
Drug developers lost days hunting for research across scattered PDFs. Now, they query an AI agent for instant answers, accelerating R&D.
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Teams spent weeks manually merging trial data. AI now generates drafts with full lineage, shifting experts to verification.
Manual scheduling trapped recruiters in logistics. AI now automates interview coordination, freeing teams for strategic work.
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Hundreds of pages per board book slowed director prep. Now, isolated AI securely condenses sensitive materials into actionable briefs.
Experts spent 15 minutes pulling data from scattered systems. Natural language prompts now generate detailed reports instantly.